Indian Procurement Reforms, Unleashing a New Era of Scientific Innovation

Indian Procurement Reforms, Unleashing a New Era of Scientific Innovation

For decades, the engine of Indian scientific research and development (R&D) has been throttled by an unlikely adversary: its own procurement rulebook. Designed with the paramount goals of transparency, accountability, and cost-efficiency, these frameworks, while successful in curbing fraud, inadvertently became a formidable barrier to innovation. Scientists and researchers at premier national laboratories and institutions found themselves entangled in a web of bureaucratic red tape, forced to prioritise procedural compliance over scientific ambition. The quest for a globally benchmarked, highly specialised piece of equipment could be delayed for months, bogged down in exemption requests and approvals for purchases that fell outside the rigid, one-size-fits-all government portal. This critical impediment stifled creativity, delayed breakthroughs, and kept India’s vast R&D potential from achieving global competitiveness.

Recognising this systemic flaw, the Government of India enacted a series of landmark reforms to its General Financial Rules (GFR) in June 2025. These changes, particularly the exemptions from the mandatory use of the Government e-Marketplace (GeM) portal for specialised R&D procurement and the enhancement of financial thresholds, mark a significant philosophical shift. They represent a bold move to reimagine public procurement not merely as a cost-control mechanism but as a powerful catalyst for innovation. This article delves into the nuances of these reforms, places them within a global context, explores the historical evolution of procurement, and outlines the future steps necessary to fully unlock India’s innovative potential.

The Core of the Reforms: Flexibility as a Catalyst

The pre-reform framework mandated that all equipment purchases below ₹200 crore (₹2200 crore as noted in the text) be routed through the GeM portal. While GeM excelled in standardising and simplifying the procurement of common goods like stationery or furniture, it was woefully inadequate for the bespoke needs of cutting-edge research. Vendors on the platform often supplied materials of inferior quality, directly compromising the integrity and outcomes of scientific experiments. For any specialised instrument not available on GeM, scientists were forced into a tedious, time-consuming exemption process, sapping valuable time and energy that should have been dedicated to research.

The June 2025 reforms directly tackle these pain points:

1. GeM Exemption for Specialised Equipment: Institutional heads (such as Vice-Chancellors and Directors of national labs) have now been empowered to bypass the GeM portal entirely for procuring specialised research equipment. This acknowledges that cookie-cutter procurement is fundamentally incompatible with the customised, high-precision demands of R&D.

2. Enhanced Financial Thresholds: The limit for direct purchases has been doubled from ₹1 lakh to ₹2 lakh, providing greater autonomy for smaller, routine acquisitions.

3. Delegated Approval for Global Tenders: The authority to approve global tenders up to ₹200 crore has been delegated to institutional leaders. This eliminates a significant layer of bureaucratic lag—a chronic grievance highlighted by the Prime Minister’s Economic Advisory Council—and dramatically accelerates the process of acquiring critical technology from international suppliers.

These adjustments are a clear embrace of the theory of “catalytic procurement,” where public institutions are granted the flexibility to act as early adopters of advanced technologies. By creating stable, sophisticated demand, the government can stimulate private-sector investment in R&D, forming a virtuous cycle of innovation. Studies have consistently shown that targeted public procurement spending is strongly associated with increased patent filings and private R&D investment.

The Global Playbook: Lessons from Germany and the United States

India’s reforms are a step in the right direction, but they are not unprecedented. Globally, nations leading in R&D outcomes have long reimagined procurement as a strategic tool for innovation.

Germany’s approach, under its High-Tech Strategy, offers a masterclass in balancing rigorous checks with ambitious R&D goals. The federal government explicitly mandates that public procurement be used to promote innovative solutions. This mission is supported by a dedicated agency, KOINNO, which advises public procurers, curates databases of innovative suppliers, and hosts cross-sector innovation forums. This institutionalises what economist Mariana Mazzucato terms “mission-oriented procurement,” where the state’s immense purchasing power is deliberately used to shape and create new technological markets, rather than just buying what already exists.

Similarly, the United States’ Small Business Innovation Research (SBIR) program is a legendary example of de-risking innovation. It legally reserves 3% of all federal external R&D funds for small businesses and startups. Crucially, it uses phased procurement contracts: starting with a smaller initial grant to prove feasibility, followed by a larger second-phase contract for development, and potentially a third phase for commercialisation. This staged funding structure maintains competitive tension among vendors while providing startups with the critical capital needed to bridge the “valley of death” between a prototype and a marketable product.

When compared to these models, India’s GeM reforms, though welcome, appear incomplete. They remove a barrier but lack the proactive, market-shaping elements of Germany’s strategy or the sophisticated, de-risking structure of the SBIR. For instance, India’s ₹200 crore global tender limit for institutional heads still ultimately prioritises cost benchmarks and procedural compliance. In contrast, South Korea’s “pre-commercial procurement” system is designed to pay premium prices for prototypes that meet ambitious “moonshot” criteria, valuing technical ambition and future potential over immediate cost savings.

The Historical Arc: From Pyramids to AI

To appreciate the significance of India’s shift, it is useful to view procurement through a historical lens. Its 5,000-year journey, from Egyptian scribes meticulously tracking materials for pyramids to modern AI algorithms predicting global supply chain disruptions, reflects a broader evolution from pure control to enabling creativity.

The Industrial Revolution cemented procurement’s role as a cost-centric, efficiency-driven function. However, the two World Wars exposed its strategic dimension in securing scarce and critical resources for national security. The post-1945 era deepened this duality: corporations adopted lean, Just-In-Time inventory systems, while governments aggressively used procurement to spur entire sectors. The U.S. semiconductor industry was born largely from the demand generated by National Aeronautics and Space Administration (NASA) and Department of Defense contracts. Similarly, the European Union’s green mandates have been instrumental in catalyzing the renewable energy sector.

Today, the frontier is “cognitive procurement.” Tools powered by generative AI can analyse vast supplier ecosystems, simulate global scarcity scenarios, automate compliance checks, and even suggest alternative materials. A powerful example is Pfizer’s effort to develop its COVID-19 vaccine. By using AI-optimised procurement, the company identified multiple critical suppliers for scarce materials within hours, compressing a process that would traditionally have taken months into a matter of weeks. This freed researchers and project managers to focus on strategic and creative sourcing, rather than administrative hurdles.

The Privatisation Debate and the Hybrid Model

A common reaction to procurement inefficiencies in public labs is a call for full-scale privatisation. However, as the provided text astutely notes, this debate often hinges on a false binary. The goal is not to choose between complete public control and total private ownership, but to intelligently blend the two into a hybrid model that leverages the strengths of each.

The U.S. experience offers a compelling blueprint. In 1993, the Department of Energy (DoE) transferred the management and operation (M&O) of the Sandia National Laboratories to a private entity, Sandia Corporation (a subsidiary of Honeywell International). Crucially, the DoE did not abdicate its responsibility. It retained strict mission control through performance-based contracts that outlined specific goals and outcomes. This model unlocked private capital, management efficiency, and agility in procurement and hiring for laser and materials research, while ensuring the lab’s work remained aligned with national interests. The result was a dramatic increase in patent filings and partnerships with small and medium enterprises within a decade.

India’s council of Governments and Industrial Research (CSIR) is a prime candidate for adopting such a hybrid governance model. Laboratories working on strategic frontiers like space technology, quantum computing, or advanced pharmaceuticals could be managed by private entities under strict government oversight. This would grant them corporate-style agility to hire top global talent and procure equipment rapidly, all while ensuring their research aligns with national innovation roadmaps. Success, however, is contingent on robust accountability frameworks and transparent, performance-linked funding.

The Road Ahead: Four Systemic Shifts for Deeper Change

While the GeM reforms are a necessary and commendable first step, they are insufficient alone to position India as a global innovation leader. Four systemic shifts could anchor a deeper transformation:

1. Outcome-Weighted Tenders: India must move beyond selecting vendors based solely on the lowest cost. Following Finland’s example, tender evaluations should incorporate a qualitative index that weights factors like the supplier’s own R&D investment, the scalability potential of the technology, its environmental impact, and its alignment with national strategic goals. This values long-term innovation capacity over short-term savings.

2. Sandbox Exemptions: Premier institutions like the Tata Institute of Fundamental Research (TIFR) or the Indian Institutes of Technology (IITs) should be granted “sandbox” exemptions. They could be allowed to bypass the GFR entirely for a certain percentage (e.g., 15-20%) of their annual procurement budget, provided they meet aggressive, pre-defined innovation targets audited by independent third parties. This creates zones of radical autonomy for high-performing labs.

3. AI-Augmented Sourcing: The government should deploy its INDIAI ecosystem to develop a national AI-powered procurement assistant for R&D institutions. This tool could scan global catalogues and scientific databases, predict customs and logistics delays, suggest alternative materials or local suppliers, and automate compliance paperwork. This has the potential to reduce decision cycles from months to hours, as seen in the Pfizer case.

4. Co-Procurement Alliances: Fragmented demand from individual labs leads to weak negotiating power and higher costs. India should replicate the European Union’s Joint Procurement Agreement model. By creating alliances that allow multiple labs (e.g., all CSIR labs, or all IITs) to aggregate their demand for high-cost items like cryogenic coolers, DNA sequencers, or electron microscopes, the system can achieve massive economies of scale, reduce costs, and attract better suppliers.

Conclusion: From Impediment to Accelerant

India’s procurement reforms signal a crucial change in mindset. They begin to value “time-to-lab”—the speed at which a critical tool reaches a researcher’s bench—as highly as cost savings. This is a foundational shift for scientific progress. By marrying these initial changes with global best practices in mission-oriented procurement, cognitive AI tools, and hybrid governance models, India has the opportunity to transform its procurement apparatus from a notorious research impediment into its most powerful accelerant.

The lesson from history is clear and profound. Civilisations that directed their procurement prowess solely toward building monuments have left behind impressive ruins. Those that procured in the service of inquiry, exploration, and knowledge—from the Enlightenment to the Space Age—are the ones who built the future. India’s recent reforms suggest it is choosing the latter path, aiming to build a future defined by discovery and innovation.

Q&A: Unpacking India’s Procurement Reforms

Q1: What was the main problem with India’s old procurement system for R&D?
A: The old system, which mandated the use of the Government e-Marketplace (GeM) for most purchases, was designed for transparency and cost-saving on standard items. For R&D, it was a poor fit. It forced scientists to use a portal where specialised, globally benchmarked equipment was often unavailable or offered by vendors supplying poor-quality materials. obtaining an exemption was a slow, bureaucratic process that could delay critical research for months, prioritising procedural compliance over scientific need and stifling innovation.

Q2: What are the three key changes introduced in the June 2025 reforms?
A: The three key changes are:

1. GeM Exemption: Institutional heads can now bypass the GeM portal for procuring specialised research equipment.

2. Higher Direct Purchase Limit: The financial threshold for direct purchases without a formal tender has been raised from ₹1 lakh to ₹2 lakh, giving labs more autonomy for small buys.

3. Delegated Approval: Vice-Chancellors and directors of institutions can now themselves approve global tenders up to ₹200 crore, eliminating a major layer of bureaucratic delay.

Q3: How does the U.S. Small Business Innovation Research (SBIR) program work, and what can India learn from it?
A: The SBIR program reserves a portion (3%) of federal R&D funds exclusively for small businesses and startups. It uses a phased procurement contract approach: a small Phase I grant to prove feasibility, a larger Phase II contract for development, and a Phase III for commercialisation. India can learn from this structured method of de-risking innovation for small players. It maintains competition while providing startups with the sustained funding needed to develop high-risk, high-reward technologies, rather than just procuring finished products.

Q4: The article warns against a “false binary” in the debate over privatising national labs. What does this mean?
A: The “false binary” is the idea that the only choices are complete government control or full privatisation. The hybrid model, as exemplified by the U.S. management of Sandia National Laboratories, shows a third way. The government retains strategic mission control and oversight through performance-based contracts, while transferring daily management and operation to a private entity. This unlocks private sector efficiency, agility in procurement, and access to capital, while ensuring the lab’s work continues to serve national interests.

Q5: What is “cognitive procurement” and how can it help Indian researchers?
A: Cognitive procurement refers to the use of advanced technologies, like generative AI, to automate and enhance procurement processes. An AI tool could scan global suppliers, predict shipping delays, suggest alternative materials, and handle compliance paperwork automatically. For Indian researchers, this would eliminate immense administrative burdens, reduce procurement decision cycles from months to hours (as seen in Pfizer’s vaccine development), and free them to focus entirely on their core research work, significantly accelerating the pace of innovation.